SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Meta Platforms, Inc. engages in the development of social media applications. It builds technology that helps people connect and share, find communities, and grow businesses. It operates through the Family of Apps (FoA) and Reality Labs (RL) segments. The FoA segment consists of Facebook, Instagram, Messenger, WhatsApp, and other services. The RL segment includes augmented, mixed and virtual reality related consumer hardware, software, and content. The company was founded by Mark Elliot Zuckerberg, Dustin Moskovitz, Chris R. Hughes, Andrew McCollum, and Eduardo P. Saverin on February 4, 2004, and is headquartered in Menlo Park, CA.

Meta Platforms Inc - Ordinary Shares - Class A

Meta Platforms Inc

Meta shares are surging double digitstheir largest single-day gain in yearsas traders point to rapid adoption of the Muse AI agent, a Wells Fargo price-target hike, and positioning ahead of the Meta Connect conference. Sentiment is split between bulls celebrating Muse's app-store momentum and bears calling the move hype-driven and overbought, with some expecting a sell-the-news reaction at Connect and others flagging Amazon's block of Muse from its shopping site.

SoFi Technologies, Inc. is a financial service platform, which engages in the provision of student loan refinancing options to the private student loan market. It operates through the following segments: Lending, Technology Platform, and Financial Services. The Lending segment offers personal loans, student loans, home loan products, and related servicing activities. The Technology Platform segment focuses on technology products and solutions revenue. The Financial Services segment includes the SoFi Money product, SoFi Invest product, SoFi Credit Card product, SoFi Relay personal finance management product, and other financial services. The company was founded in April 2011 and is headquartered in San Francisco, CA.

SoFi Technologies Inc

SoFi is trending as traders vent over the stock trading flat to lower during a broad market rally while fintech peers like Robinhood surge, renewing debate over whether the shares are undervalued or structurally impaired by dilution and leadership criticism. Heavy attention is also on Citizens Bank's lawsuit accusing SoFi of racketeering over the poaching of mortgage employees, which some traders dismiss as a legal scare tactic while others believe it has merit.

Critical Metals Corp. engages in the mining, exploration, and development of lithium metals. It owns Wolfsberg Project and Tanbreez Project. The company was founded on October 24, 2022 and is headquartered in British Virgin Islands.

Critical Metals Corp.

Critical Metals is surging after President Trump announced a U.S.-Denmark-Greenland security agreement that traders see as de-risking and potentially accelerating development of the company's Tanbreez rare-earth project, driving a broader rally in Greenland-linked stocks. Extremely bullish sentiment is amplified by heavy short interest and squeeze speculation, while skeptics counter that the pact grants no mining rights and warn of sell-the-news risk around the planned Trump-Xi meeting on critical minerals.

Paramount Skydance Corp. is a next-generation global media and entertainment company that engages in providing content creation and distribution services. It operates through the following business segments: Studios, Direct-to-Consumer, and TV Media. Its portfolio unites brands including Paramount Pictures, Paramount Television, CBS, CBS News, Nickelodeon, MTV, BET, Comedy Central, Showtime, Paramount Plus, Pluto TV, and Skydance’s Animation, Film, Television, Interactive/Games, and Sports divisions. The company is headquartered in New York, NY.

Paramount Skydance Corp. - Ordinary Shares - Class B

Paramount Skydance is trending on reports that it reached a settlement with California and other state attorneys general whose lawsuit had blocked its merger with Warner Bros. Discovery, clearing a major legal hurdle for the deal. Community reaction is mixed: bulls treat the merger as effectively cleared and speculate about a short squeeze, while skeptics point to the lack of official confirmation, criticize settlement terms such as editorial oversight commitments, and flag persistent selling pressure despite the headlines.

Advanced Micro Devices, Inc. engages in the semiconductor business. Its products include processors, accelerators, graphics, adaptive SoCs, FPGAs, and SOMs, and software, tools, and apps. The firm offers artificial intelligence, industries, workloads, and gaming solutions. The company was founded by W. J. Sanders III on May 1, 1969 and is headquartered in Santa Clara, CA.

Advanced Micro Devices Inc.

Advanced Micro Devices Inc

AMD is surging to record highs and briefly crossing the trillion-dollar market-cap milestone amid a broad semiconductor rally driven by AI demand, with peers like Intel and Arm gaining sharply as well. Community reaction is split, with bulls celebrating the milestone and eyeing further upside while bears call the move overextended on stretched valuation, and some traders locking in profits or opening short positions.

Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care and Rare Disease segments. The Diabetes and Obesity Care segment includes diabetes, obesity, cardiovascular, and emerging therapy areas. The Rare Disease segment refers to rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company was founded by Harald Pedersen and Thorvald Pedersen in 1923 is headquartered in Bagsværd, Denmark.

Novo Nordisk - ADR

Novo Nordisk A/S

Novo Nordisk shares slid after its Capital Markets Day, where long-term pipeline targets through 2035 and revenue growth guided only "in line with peers" failed to ease concerns over semaglutide patent expirations and competition from Eli Lilly. Reaction is split between bears faulting CEO Mike Doustdar's communication and the muted growth outlook, and dip-buyers calling the selloff an overreaction at historically low valuations.

Direxion Shares ETF Trust - Direxion Daily Semiconductor Bear 3X ETF

Direxion Daily Semiconductor Bear 3X ETF

SOXS is trending as it slides sharply alongside a strong semiconductor rally, drawing heavy dip-buying from traders positioning for an eventual reversal in the AI-driven chip trade, while others warn the leveraged ETF's structural decay makes holding it a losing battle. The debate pits bears citing hawkish rate-hike expectations, inflation, and AI-bubble concerns against bulls mocking the short thesis as the sector keeps climbing.

Dogecoin is an open-source digital currency based on the "Doge" meme that functions as a peer-to-peer medium for fast payments and digital tipping. Unlike projects backed by corporate entities, its value is driven by a global community, and the project is managed by a decentralized group of volunteers and the non-profit Dogecoin Foundation rather than a formal company.  Originally created in 2013 by software engineers Billy Markus and Jackson Palmer as a market parody, the project held no public sale or venture capital rounds. The network operates as a fork of LuckyCoin, which itself was a fork of Litecoin, using a proof of work consensus mechanism. It employs the Scrypt algorithm to ensure the mining process remains fast and efficient, with new blocks processed every 60 seconds. A unique technical feature is its use of merged mining, allowing miners to secure Dogecoin simultaneously with other Scrypt-based networks like Litecoin.  To keep transaction fees low and the network running indefinitely, Dogecoin features an uncapped supply where new coins are added forever. In a major regulatory milestone in March 2026, a joint SEC and CFTC framework officially classified Dogecoin as a digital commodity, placing it in the same asset category as gold or oil.

Dogecoin

Traders are driving Dogecoin sharply higher as it presses against the psychological $0.10 resistance level, with bulls urging continued buying to force a breakout and bears warning that longtime holders could sell heavily into any move above it. The rally is playing out against broader crypto momentum tied to Bitcoin's direction and reaction to the Senate's failure to pass the Clarity Act, with the CFTC saying it will still move forward with its own crypto rules.

Shopify, Inc. is a global commerce company that provides essential internet infrastructure for commerce, offering trusted tools to start, scale, market, and run a retail business of any size. The Company's software enables merchants to run their business across all of their sales channels, including web and mobile storefronts, physical retail locations, social media storefronts and marketplaces. The Shopify platform provides merchants with a single view of their business across all of their sales channels and enables them to manage products and inventory, process orders and payments, fulfill and ship orders, build customer relationships, source products, leverage analytics and reporting and access financing, all from one integrated back office. The company was founded on September 28, 2004 and is headquartered in Ottawa, Canada.

Shopify Inc - Ordinary Shares - Class A (Sub Voting)

Shopify Inc

Traders are attributing the stock's rally to a partnership placing Shop Pay inside Meta's Muse AI shopping assistant to enable agentic checkout across Shopify stores, with no financial terms or rollout timing disclosed. Reaction is split between bulls touting the merchant-wide scale of the integration and skeptics warning that AI shopping agents could disintermediate e-commerce platforms, while the stock also attempts to reclaim its 200-day moving average.

Daily surprises, near and far. Your source for travel inspiration and more. Travel moves you!

Warner Bros. Discovery Inc - Ordinary Shares - Class A

Warner Bros Discovery Inc

Paramount Skydance's reported settlement with California and other states that sued to block its acquisition of Warner Bros. Discovery has cleared a major legal hurdle, sending WBD sharply higher. The community is celebrating the rally while debating whether to lock in gains or hold through the expected closing, with some cautioning that the state AG called the settlement no endorsement of the merger and a separate Writers Guild lawsuit remains pending.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Sensei Biotherapeutics Announces Name Change to Faeth Therapeutics, Focused on Advancing PIKTOR, an Oral Therapy Targeting One of the Most Frequently Altered Pathways in Cancer

Sensei Biotherapeutics, Inc. (Nasdaq: SNSE) today announced that it has changed its corporate name to Faeth Therapeutics, Inc. (the Company). The Companys common stock is expected to begin trading on the Nasdaq Capital Market under the new ticker symbol FTH on June 16, 2026, and the Company has...

Sensei Biotherapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Sensei Biotherapeutics, Inc. (Nasdaq: SNSE) today announced that, effective on June 1, 2026, the Compensation Committee of Senseis Board of Directors granted three new employees options to purchase an aggregate of 19,300 shares of the Companys common stock in connection with their employment...

Sensei Biotherapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update

Sensei Biotherapeutics, Inc. (Nasdaq: SNSE) today reported financial results for the first quarter ended March 31, 2026, and provided a corporate update. The first quarter of 2026 was...

Sensei Biotherapeutics Doses First Patient in Phase 1b/2 Trial of PIKTOR in HR+/HER2- Advanced Breast Cancer

Sensei Biotherapeutics, Inc. (Nasdaq: SNSE), a clinical-stage biotechnology company, announced today that the first patient was dosed in Study FTH-PIK-101 (NCT07558733), a Phase 1b/2 trial of PIKTOR...

Sensei Biotherapeutics to Present at the 25th Annual Needham Virtual Healthcare Conference

Sensei Biotherapeutics, Inc. (Nasdaq: SNSE) today announced that Company management will present at the 25th Annual Needham Virtual Healthcare Conference on Thursday, April 16th, 2026 at 12:45 p.m...

Sensei Biotherapeutics Reports Full Year 2025 Financial Results and Provides Corporate Update

Sensei Biotherapeutics, Inc. (Nasdaq: SNSE) today reported financial results for the full year ended December 31, 2025, following its previously announced acquisition of Faeth Therapeutics and...

Sensei Biotherapeutics, Inc. (Nasdaq: SNSE) today announced that, effective on March 11, 2026, Senseis Board of Directors granted a new employee an option to purchase 166,435 shares of the Companys...

Sensei Biotherapeutics, Inc. (Nasdaq: SNSE) today announced that, effective on February 19, 2026, Senseis Board of Directors granted 17 new employees, in the aggregate, options to purchase 2,319,893...

Small Cap Stocks To Add to Your Watchlist - February 18th

Rackspace Technology, Direxion Daily PLTR Bear 1X Shares, Spring Valley Acquisition, Direxion Daily MU Bull 2X Shares, Sensei Biotherapeutics, Inflection Point Acquisition Corp. II, and Direxion...

 SNSE Stock Surges To 21-Month High – Everything To Know About Its Faeth Therapeutics Acquisition

Equity

The company said that the acquisition adds Faeth’s lead investigational therapy, PIKTOR, to its oncology portfolio.

Faeth Therapeutics, Inc. is a clinical-stage biopharmaceutical company which focuses on the discovery, development, and delivery of next generation immunotherapies for the treatment of cancer and infectious diseases. The company was founded in 1999 and is headquartered in Austin, TX.

Faeth Therapeutics Inc.

Bullish Sentiment

Rising interest rates

Surging bond yields

Oil/energy volatility

Trump/political risk

U.S. investors are navigating a stacked macro backdrop, with the Federal Reserve hiking rates for the first time since July 2023, the 10-year Treasury yield hitting 5.00% - its highest level since 2007 - and oil prices swinging between $94 and $105 a barrel amid the ongoing U.S.-Iran conflict and Saudi pipeline disruptions. What's the biggest risk to your portfolio right now? Vote and explain your reasoning in the comments.

With the Fed hiking rates for the first time since 2023, the 10-year Treasury yield near 5%, and oil prices swinging on the U.S.-Iran conflict, what&#39;s the biggest risk to your portfolio right now?

Stocktwits

With the Fed hiking rates for the first time since 2023, the 10-year Treasury yield near 5%, and oil prices swinging on the U.S.-Iran conflict, what's the biggest risk to your portfolio right now?

Microsoft Corp

SELLAS Life Sciences Group Inc

Alphabet Inc Class A

CoreWeave Inc

SpaceX

Stocktwits Polls

Sensei Biotherapeutics Inc

$SNSE this is whar happens when the feds raise interest rates. raising rates, all prices will go up creating higher inflation and stock market frops

m graves

$SNSE love it another day like today and i can buy more, or are we headed down to 24.00 like the last time we hit a new high?

$SNSE Seems this is still THE stock twits board of preferences-  for - the usual pumpers, fudsters, fans , bots and former meme investors - 
Also, you contributors that are serious about the steps that the company is taking to assure a future profit  …~the press releases, filings, approvals, offerings, loans  ..a lot. . 

Someone on the AXSM board suggested I look at this for a similar, share appreciation story   (TY to them) 

/// And why dont any of you post on FTH ? Just wonder.

:)

Feed

News

Sentiment

Earnings

Fundamentals

Info

SNSE Sensei Biotherapeutics Inc

Fundamentals

Latest SNSE News